Evidence map›Paper›PMID 41562045›Full record

ArticleCase reports in infectious diseases2026

Incidence and Clinical Outcomes of COVID-19 in Maintenance Hemodialysis Patients in Libya: A Prospective Descriptive Study.

Nada Elgriw, Eman Gusbi, Halla Elshwekh, Jamal Elcosbi, Inas Alhudiri, Ezedeen M Belhaj, Aymen M Alamin, Adam Elzagheid, Nabil Enattah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nada ElgriwMicrobiology Department, Biotechnology Research Center, Tripoli, Libya.ORCID https://orcid.org/0000-0001-6383-2806
Eman GusbiPhysiology Department, University of Tripoli, Tripoli, Libya, uot.edu.ly.ORCID https://orcid.org/0009-0004-3069-5031
Halla ElshwekhGenetic Engineering Department, Biotechnology Research Center, Tripoli, Libya.ORCID https://orcid.org/0000-0003-4100-6743
Jamal ElcosbiPhysiology Department, University of Tripoli, Tripoli, Libya, uot.edu.ly.
Inas AlhudiriGenetic Engineering Department, Biotechnology Research Center, Tripoli, Libya.ORCID https://orcid.org/0000-0002-3371-0215
Ezedeen M BelhajTripoli Hemodialysis Center, Tripoli, Libya.
Aymen M AlaminTripoli Hemodialysis Center, Tripoli, Libya.
Adam ElzagheidGenetic Engineering Department, Biotechnology Research Center, Tripoli, Libya.ORCID https://orcid.org/0000-0002-7086-5937
Nabil EnattahGenetic Engineering Department, Biotechnology Research Center, Tripoli, Libya.ORCID https://orcid.org/0000-0001-6393-9507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemodialysis patients are at a greater risk of severe disease from COVID-19. Of the 600 maintenance hemodialysis patients who were regular attendees at the Tripoli Hemodialysis Center in Tripoli, Libya, 12 patients tested positive for SARS-CoV-2 infection. The patients' ages ranged from 48 to 80 years. Three were female (25%), and four (33.3%) reported prior contact with a confirmed case. The most common symptoms were fever (66.7%), dry cough (66.7%), dyspnea (91.7%), and fatigue (83.3%). Chest computed tomography revealed radiological features consistent with COVID-19 pneumonia, including ground-glass opacities and pulmonary consolidation in all patients. Four of the patients died (33.3%). COVID-19 represents a significant comorbidity in maintenance hemodialysis patients and is associated with a notably high mortality rate. In the absence of specific operational guidelines, tailored protocols should be developed, or existing guidelines-such as those from the CDC-should be adapted to fit the local healthcare context.

Indexed as

chestCOVID-19hemodialysisPCR

Identifiers

PMID41562045
PMCPMC12813615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.